{
  "id": "sequoia:biomodal",
  "sequoia_id": "12966",
  "name": "biomodal",
  "slug": "biomodal",
  "description": "biomodal is an omics based life-sciences technology and analytics company delivering products that bring the dynamism of our ever-changing biology into focus. Their duet multiomics solution enables more epigenetic information from a single, low input DNA library without complex, resource intensive bioinformatics or harsh chemical treatment. Their single-base-resolution, phased sequencing approach unlocks the combinatorial power of genetic and epigenetic information in one workflow, elucidating greater biological insight within the fields of cancer, neurodegenerative disease, and ageing.",
  "website": "https://www.biomodal.com",
  "socials": {
    "twitter": "https://twitter.com/biomodalhq",
    "linkedin": "https://www.linkedin.com/company/biomodal"
  },
  "categories": [
    "healthcare"
  ],
  "current_stage": "growth",
  "first_partnered_year": 2016,
  "partners": [
    "roelof-botha"
  ],
  "primary_partner": "roelof-botha",
  "milestones": {
    "founded_year": 2012,
    "partnered_year": 2016,
    "ipo_year": null,
    "acquired_year": null
  },
  "team": [
    {
      "name": "Peter Fromen",
      "role": null
    },
    {
      "name": "Shankar Balasubramanian",
      "role": null
    },
    {
      "name": "Bobby Yerramilli-Rao",
      "role": null
    }
  ],
  "why_partnered": null,
  "source_urls": {
    "directory": "https://sequoiacap.com/our-companies/",
    "profile": "https://sequoiacap.com/companies/biomodal/"
  }
}
